Atlas Trials

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Clinical trial NCT05898464 · COMPLETED

Trial details

NCT number
NCT05898464
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Vaccination; InfectionVaccine Adverse Reaction
Start date
2023-06-27
Primary completion
2026-02-10
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.